Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice

Vaccine

Volumn 19, Issue 6, 2000, Pages 648-654

  Ocazionez Jimenez, Raquel ^a,b   Lopes Da Fonseca, Benedito Antônio ^b  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dengue; DNA vaccine; Glycoprotein E

Indexed keywords

CYTOKINE; DENGUE VACCINE; DNA VACCINE; GLYCOPROTEIN E; PROTEIN PRM; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELL PROLIFERATION; DENGUE VIRUS; DENGUE VIRUS 2; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; RECOMBINANT DNA TECHNOLOGY; RECOMBINANT PLASMID; SURVIVAL TIME; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CYTOKINES; DENGUE; FEMALE; GENETIC VECTORS; MICE; MICE, INBRED BALB C; SEQUENCE DELETION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0034623662     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00247-4     Document Type: Article

References (34)

1. Classification and nomenclature of viruses: fifth report of the International Committee on Taxonomy of viruses
2. Dengue
3. Pathogenesis of dengue: challenges to molecular biology
4. Dengue and dengue hemorrhagic fever
5. The dengue viruses
6. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
7. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting
8. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form
9. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice
10. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein
11. Structural changes and functional control association with protein prM
12. Increased immmnunogenicity. and protective efficacy in out-bred and inbred mice by strategic carboxil-terminal tuncation of Japanese encephalitis virus envelope glycoprotein
13. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellulary exhibit increased immunogenicity in mice
14. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus
15. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes
16. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice
17. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice
18. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses
19. A method for the isolation and identification of dengue viruses, using mosquito cell cultures
20. Biotinylation: an alternative to radioiodination for the identification of cell surface antigens in immunoprecipitates
21. Evaluation of Vero cell lysate antigen for the ELISA of flaviviruses
22. CpG motifs in bacterial DNA trigger direct B-cell activation
23. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
24. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment
25. Immune responses to nucleic acid vaccines to rabies virus
26. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice
27. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors
28. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells
29. Processing, secretion and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculovirus
30. DNA vaccines: protective immunization by parenteral, mucosal, and gene-gun inoculations
31. Direct gene transfer into mouse diaphragm
32. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs
33. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus
34. DNA vaccination against persistent viral infection